Categories

Tag: Embold Health

#HealthTechDeals Episode 17: Cricket Health, Embold Health, Canopy, Vira Health, and Woebot

We’ve reViVEd from ViVE and the HIMMSanity is over! Jess and I are back to discuss more multimillion-dollar deals: Fresenius/Interwell/Cricket Health is merging to 2.4 billion valuation; Embold Health gets $26 million; Canopy gets $13 million; Vira Health gets $12 million; and Woebot gets $9 million.

-Matthew Holt

Jess DaMassa:

While we revived from Vive and the HIMSS-sanity is over and all that’s left is boring old Matthew Holt and I to pick up the pieces. It can only be the March 22nd episode of Health Tech Deals.

Matthew Holt:

So Jess, I had massive HIMSS FOMO. First time hadn’t been in like 428 years and everyone else was there. And did you care? No?

Jess DaMassa:

I’m two hours away and I’m like, “Nope. Not for me. Not right now.”

Continue reading…

Health in Two Point 00 – The LAST Episode (247)

It’s the very last episode of Health in Two Point 00! (We’re not going away just changing the name next week). Six deals in 2 minutes! Embold Health gets $20m; Brainomix gets $21m; $25m for Zing Health; Quartet buys Innova Tel; Prolucent Health gets $11m; and Mightier gets $17m. And now we are done with 2021! And to announce the new name, we are wearing evening dress! – Matthew Holt

Local Doctors Get the “Centers of Excellence” Treatment: Embold Health’s CEO on Data-Driven Quality

By JESSICA DaMASSA, WTF HEALTH

Apparently, self-insured employers hot on better managing their healthcare spend are finding truth (and dollars) in Embold Health’s mantra that “quality is the best, most sustainable way to control costs.” This health tech startup is applying the old “Centers of Excellence” framework to the individual physician level; helping identify high-performing primary care docs and specialists in local markets for employers who not only want to offer their employees better quality care, but also improve the healthcare system in the communities in which they live and work.

Daniel Stein, Embold Health’s co-Founder & CEO, explains the company’s model, which is being perfected with one of the most demanding-yet-coveted “health activist” employers out there: Walmart. In this particular case, Walmart is actually incentivizing its employees to go to the providers ranked highest by Embold’s assessment, which looks at physician performance along three categories: 1) appropriateness of care; 2) outcomes; and 3) cost-effective compared to peers in-market. Backed by the robust national BlueCross BlueShield dataset, the information Embold Health is collecting, analyzing, and doling out to employers can definitely cause some health systems to take pause — and their docs to bristle. So, how does Embold Health diffuse potential blowback? Here’s where the competitive nature of local healthcare, particularly in the world of primary care, becomes clutch. Tune in to hear the details, including some very interesting stats, as well as Embold’s latest endeavors to help docs make better referrals to specialists.

Health in 2 Point 00, Episode 97 | Walmart and Fertility

Today on Health in 2 Point 00, Jess is in Berlin for the Bayer G4A Signing Day where they’re announcing which startups are going to get deals and Glen Tullman is doing a fireside chat with Eugene Borukhovich. In Episode 97, Jess and I talk about Walmart and fertility. Fertility benefits startup Progyny files for IPO and I’m blown away by this relatively new company. Another startup—Halle Tecco’s Natalist—raises $5M to send care boxes to help women get pregnant. Finally, Jess has a conspiracy theory, noticing that Walmart is sneaking into all aspects of health tech… Walmart is expanding Grand Rounds, partnering with Doctor On Demand and HealthSCOPE to offer telehealth to their employees, Sam’s Club is offering $1 telehealth visits to members, and they just announced a partnership with Embold Health for employees in the southeast. Finally, I’ll be at Society for Participatory Medicine next week in Boston—see you all there. —Matthew Holt

fs25 mods